Ezetimibe
Prescription status is set country by country — the label where you live is the one that applies.
Beta: the medication section is still being tested, and its data may contain errors. Do not rely on it for a decision about your own treatment.
Ezetimibe is a lipid-lowering drug that works in the small intestine rather than the liver. It blocks the transporter that absorbs cholesterol from food and bile, so less cholesterol reaches the bloodstream and the liver pulls more of it out of circulation. It is prescribed to lower cholesterol, either on its own or alongside a statin when LDL remains above target.
A usual adult range, not a national label — the dose and the timing differ by country and by product.
Approved uses differ by country — some of these may be off-label or unapproved where you live.
It can be taken with or without food, and at whatever time of day is easiest to remember consistently, since the effect depends on steady daily use rather than timing. The point of the treatment is visible only in bloodwork, so LDL cholesterol is checked to judge whether it is working. ALT is followed as well, because liver enzymes can rise, particularly when the drug is combined with a statin.
Persistent tiredness, loss of appetite, dark urine or yellowing of the skin or eyes suggest a liver problem and are reasons to see a doctor rather than wait for the next scheduled test.
Reference information, not medical advice. Discuss any change with your doctor.